These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33474593)

  • 41. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lead optimization of a novel series of imidazo[1,2-a]pyridine amides leading to a clinical candidate (Q203) as a multi- and extensively-drug-resistant anti-tuberculosis agent.
    Kang S; Kim RY; Seo MJ; Lee S; Kim YM; Seo M; Seo JJ; Ko Y; Choi I; Jang J; Nam J; Park S; Kang H; Kim HJ; Kim J; Ahn S; Pethe K; Nam K; No Z; Kim J
    J Med Chem; 2014 Jun; 57(12):5293-305. PubMed ID: 24870926
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting dormant phenotype acquired mycobacteria using natural products by exploring its important targets:
    Sharma S; Chikhale R; Shinde N; Khan AM; Gupta VK
    Front Cell Infect Microbiol; 2023; 13():1111997. PubMed ID: 37033483
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Andrographolide: A potent antituberculosis compound that targets Aminoglycoside 2'-N-acetyltransferase in Mycobacterium tuberculosis.
    Prabu A; Hassan S; Prabuseenivasan ; Shainaba AS; Hanna LE; Kumar V
    J Mol Graph Model; 2015 Sep; 61():133-40. PubMed ID: 26245695
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proteome-wide subtractive approach to prioritize a hypothetical protein of XDR-Mycobacterium tuberculosis as potential drug target.
    Uddin R; Siddiqui QN; Sufian M; Azam SS; Wadood A
    Genes Genomics; 2019 Nov; 41(11):1281-1292. PubMed ID: 31388979
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel drug targets for Mycobacterium tuberculosis: 2-heterostyrylbenzimidazoles as inhibitors of cell wall protein synthesis.
    Anguru MR; Taduri AK; Bhoomireddy RD; Jojula M; Gunda SK
    Chem Cent J; 2017 Jul; 11(1):68. PubMed ID: 29086847
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Toward the virtual screening of potential drugs in the homology modeled NAD+ dependent DNA ligase from Mycobacterium tuberculosis.
    Singh V; Somvanshi P
    Protein Pept Lett; 2010 Feb; 17(2):269-76. PubMed ID: 20214650
    [TBL] [Abstract][Full Text] [Related]  

  • 48. QcrB in Mycobacterium tuberculosis: The new drug target of antitubercular agents.
    Bahuguna A; Rawat S; Rawat DS
    Med Res Rev; 2021 Jul; 41(4):2565-2581. PubMed ID: 33400275
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Probing the structure of Mycobacterium tuberculosis MbtA: model validation using molecular dynamics simulations and docking studies.
    Maganti L; Open Source Drug Discovery Consortium ; Ghoshal N
    J Biomol Struct Dyn; 2014; 32(2):273-88. PubMed ID: 23527569
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of glucosyl-3-phosphoglycerate phosphatase as a novel drug target against resistant strain of Mycobacterium tuberculosis (XDR1219) by using comparative metabolic pathway approach.
    Uddin R; Zahra NU; Azam SS
    Comput Biol Chem; 2019 Apr; 79():91-102. PubMed ID: 30743161
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
    Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
    Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cluster-based molecular docking study for in silico identification of novel 6-fluoroquinolones as potential inhibitors against Mycobacterium tuberculosis.
    Minovski N; Perdih A; Novic M; Solmajer T
    J Comput Chem; 2013 Apr; 34(9):790-801. PubMed ID: 23280926
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Computational discovery of potent drugs to improve the treatment of pyrazinamide resistant Mycobacterium tuberculosis mutants.
    Jagadeb M; Rath SN; Sonawane A
    J Cell Biochem; 2018 Sep; 119(9):7328-7338. PubMed ID: 29761826
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MmpS5-MmpL5 Transporters Provide
    Maslov DA; Shur KV; Vatlin AA; Danilenko VN
    Pathogens; 2020 Feb; 9(3):. PubMed ID: 32121069
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel inhibitor of indole-3-glycerol phosphate synthase with activity against multidrug-resistant Mycobacterium tuberculosis.
    Shen H; Wang F; Zhang Y; Huang Q; Xu S; Hu H; Yue J; Wang H
    FEBS J; 2009 Jan; 276(1):144-54. PubMed ID: 19032598
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative modeling and dynamic simulation of UDP-N-acetylmuramoyl-alanine ligase (MurC) from Mycobacterium tuberculosis through virtual screening and toxicity analysis.
    Isa MA
    Life Sci; 2020 Dec; 262():118466. PubMed ID: 32961233
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exploration of Novel Human Tyrosinase Inhibitors by Molecular Modeling, Docking and Simulation Studies.
    Hassan M; Ashraf Z; Abbas Q; Raza H; Seo SY
    Interdiscip Sci; 2018 Mar; 10(1):68-80. PubMed ID: 27098808
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design, synthesis and biological activity of N-(2-phenoxy)ethyl imidazo[1,2-a]pyridine-3-carboxamides as new antitubercular agents.
    Wang A; Lv K; Li L; Liu H; Tao Z; Wang B; Liu M; Ma C; Ma X; Han B; Wang A; Lu Y
    Eur J Med Chem; 2019 Sep; 178():715-725. PubMed ID: 31229874
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and antimycobacterial activity of imidazo[1,2-b][1,2,4,5]tetrazines.
    Maslov DA; Korotina AV; Shur KV; Vatlin AA; Bekker OB; Tolshchina SG; Ishmetova RI; Ignatenko NK; Rusinov GL; Charushin VN; Danilenko VN
    Eur J Med Chem; 2019 Sep; 178():39-47. PubMed ID: 31176094
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Syntheses and studies of deuterated Imdiazo[1,2-a]pyridine-3-carboxamides with potent anti-tuberculosis activity and improved metabolic properties.
    Liu R; Marshall K; Ma R; Lien Thi Pham K; Shetye G; Liu Z; Cho S; Jeong H; Franzblau SG; Moraski GC; Miller MJ
    Bioorg Chem; 2022 Nov; 128():106074. PubMed ID: 35987188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.